EchoSolv AS vs Viz AAA
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department requires an AI-powered clinical decision support platform to accurately and rapidly identify patients at risk for severe aortic stenosis from echocardiogram measurements. This tool is ideal for providing consistent probability assessments and guideline checks, acting as a second reader to prioritize studies for closer review within existing PACS workflows.
View EchoSolv AS →Choose Viz AAA if…
Choose Viz AAA if your emergency medicine or radiology department needs an AI-powered solution for the automatic detection and rapid triage of suspected abdominal aortic aneurysms from CT angiography scans. This platform excels at accelerating diagnosis and care coordination by providing real-time alerts and a secure communication channel for multidisciplinary teams, improving patient outcomes for AAA.
View Viz AAA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | Viz AAA |
|---|---|---|
| Pricing | Unknown | Enterprise (hospital/health system) |
| Deployment | Cloud-based | Cloud-based, integrates with PACS and EHR systems. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAWhile both tools emphasize integration into existing workflows, Viz AAA offers a more comprehensive usability experience with real-time alerts, mobile access to high-fidelity imaging, and a HIPAA-compliant communication platform for multidisciplinary teams, streamlining care coordination beyond just detection. EchoSolv AS focuses on fast, measurement-based analysis within existing echo workflows, but lacks the broader communication and mobile imaging features.
Clinical Value
EchoSolv ASEchoSolv AS has demonstrated near-perfect accuracy in detecting severe AS, outperforming traditional clinical interpretation and identifying high-risk patients often missed by conventional guidelines, which significantly enhances diagnostic precision and addresses diagnostic equity. Viz AAA also shows high accuracy for AAA detection and triage, but EchoSolv's ability to uncover previously missed cases and improve diagnostic consistency gives it a slight edge in expanding clinical value.
Pricing & Value
EchoSolv ASWhile neither tool provides public pricing tiers, EchoSolv AS explicitly mentions being backed by existing US reimbursement codes and having a clear pathway toward a dedicated Category III CPT code, which significantly enhances its economic value proposition and transparency for healthcare providers. Viz AAA's subscription model, based on algorithms and population, lacks this level of detail for a direct value comparison.
Enterprise Readiness
Viz AAABoth tools are FDA-cleared, HIPAA compliant, and cloud-based. However, Viz AAA, as part of the Viz.ai One platform, offers a more comprehensive enterprise solution with its integrated HIPAA-compliant communication platform, seamless EHR and PACS integration, and support from Microsoft Cloud for Healthcare, demonstrating broader scalability and interoperability across a health system.
Innovation
Viz AAAViz AAA stands out as the first FDA-cleared AI solution for AAA detection and triage, showcasing pioneering innovation in its specific domain. Furthermore, it is part of Viz.ai's broader platform with over 50 FDA-cleared AI algorithms and an integrated care coordination system, demonstrating a more expansive and impactful innovative approach across multiple disease states.
Support & Docs
Viz AAAViz AAA provides a clearly defined and comprehensive support structure, including a dedicated customer success team, clinical and workflow specialists, and 24x7 urgent support with a guaranteed response time. No comparable information regarding specific support offerings or documentation was found for EchoSolv AS.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | Viz AAA |
|---|---|---|
| Name | EchoSolv AS | Viz AAA |
| Company | Echo IQ | Viz.ai |
| Description | EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. | Viz AAA is the first FDA-cleared AI-powered solution by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination. |
| Primary Clinical Focus | Severe Aortic Stenosis | Abdominal Aortic Aneurysm (AAA) |
| Data Input Type | Echocardiogram measurements (numerical measurements) | CT angiography scans |
| Key Feature 1 | AI-powered clinical decision support for severe aortic stenosis probability | AI-powered automatic detection of suspected AAA from CTA scans |
| Key Feature 2 | Consistent severe AS probability and guideline check from measurements | Automated triage and prioritization of cases |
| Key Feature 3 | Second reader support to help prioritize studies for closer review | Integration into existing hospital workflows |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and Viz AAA.